TrioMedica

TrioMedica was a specialty pharmaceutical and medical technology company based in Marlton, New Jersey, dedicated to developing innovative solutions for dermatological and podiatric care. The company's flagship product, Trio-Stat, is a clear, topical hemostatic agent designed to rapidly control minor bleeding during surgical procedures and wound management. TrioMedica focused on addressing clinical gaps in skin health and surgical recovery through its specialized product portfolio. In October 2016, the company's assets were acquired by Acelity, a global leader in advanced wound care, to expand its surgical and wound care offerings. Following Acelity's acquisition by 3M in 2019, TrioMedica's technology was integrated into 3M's medical solutions portfolio.